APO Research
Talk to an analyst

APO RESEARCH · REPORT

Codeine Tablet

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Codeine Tablet Market Outlook and Growth Opportunities 2026

2 January 2026193 pages

Choose your research edition.

Industry ResearchCodeine Tablet Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Codeine Tablet Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Codeine Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Codeine Tablet Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Codeine Tablet Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Codeine Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Codeine Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Codeine Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Codeine Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Codeine Tablet market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Codeine Tablet market include TEVA, Johnson & Johnson, Novartis, Mylan, Taiji, Sanofi Aventis, Pharmaceutical Associates, Medreich and Mallinckrodt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Codeine Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Codeine Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Codeine Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Codeine Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.

Codeine Tablet Segment by Company

TEVA

Johnson & Johnson

Novartis

Mylan

Taiji

Sanofi Aventis

Pharmaceutical Associates

Medreich

Mallinckrodt

Lannett Company

Laboratoire Riva

Hikma

Cipla

Aristo Pharma GmbH

Apotex

Codeine Tablet Segment by Type

Single-ingredient Codeine

Multi-ingredient Medications

Codeine Tablet Segment by Application

Narcotic Analgesic

Antitussive

Others

Codeine Tablet Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Codeine Tablet status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Codeine Tablet market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Codeine Tablet significant trends, drivers, influence factors in global and regions.

6. To analyze Codeine Tablet competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Codeine Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Codeine Tablet market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Codeine Tablet industry.

Chapter 3: Detailed analysis of Codeine Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Codeine Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Codeine Tablet in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Codeine Tablet Industry Trends Table 2. Codeine Tablet Industry Drivers Table 3. Codeine Tablet Industry Opportunities and Challenges Table 4. Codeine Tablet Industry Restraints Table 5. Global Codeine Tablet Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Codeine Tablet Revenue Share by Company (2021-2026) Table 7. Global Codeine Tablet Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Codeine Tablet Sales Volume Share by Company (2021-2026) Table 9. Global Codeine Tablet Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Codeine Tablet Company Ranking, (2024-2026) & (USD Million) Table 11. Global Codeine Tablet Key Company Manufacturing Base & Headquarters Table 12. Global Codeine Tablet Company, Product Type & Application Table 13. Global Codeine Tablet Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Codeine Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Single-ingredient Codeine Table 18. Significant Companies of Multi-ingredient Medications Table 19. Global Codeine Tablet Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Codeine Tablet Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Codeine Tablet Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Codeine Tablet Sales Volume Share by Type (2021-2026) Table 23. Global Codeine Tablet Sales Volume Share by Type (2027-2032) Table 24. Global Codeine Tablet Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Codeine Tablet Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Codeine Tablet Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Codeine Tablet Sales Value Share by Type (2021-2026) Table 28. Global Codeine Tablet Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Narcotic Analgesic Table 30. Significant Companies of Antitussive Table 31. Significant Companies of Others Table 32. Global Codeine Tablet Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Codeine Tablet Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Codeine Tablet Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Codeine Tablet Sales Volume Share by Application (2021-2026) Table 36. Global Codeine Tablet Sales Volume Share by Application (2027-2032) Table 37. Global Codeine Tablet Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Codeine Tablet Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Codeine Tablet Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Codeine Tablet Sales Value Share by Application (2021-2026) Table 41. Global Codeine Tablet Sales Value Share by Application (2027-2032) Table 42. Global Codeine Tablet Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Codeine Tablet Sales by Region (2021-2026) & (K Units) Table 44. Global Codeine Tablet Sales Market Share by Region (2021-2026) Table 45. Global Codeine Tablet Sales by Region (2027-2032) & (K Units) Table 46. Global Codeine Tablet Sales Market Share by Region (2027-2032) Table 47. Global Codeine Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Codeine Tablet Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Codeine Tablet Sales Value Share by Region (2021-2026) Table 50. Global Codeine Tablet Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Codeine Tablet Sales Value Share by Region (2027-2032) Table 52. Global Codeine Tablet Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Codeine Tablet Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Codeine Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Codeine Tablet Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Codeine Tablet Sales by Country (2021-2026) & (K Units) Table 57. Global Codeine Tablet Sales Market Share by Country (2021-2026) Table 58. Global Codeine Tablet Sales by Country (2027-2032) & (K Units) Table 59. Global Codeine Tablet Sales Market Share by Country (2027-2032) Table 60. Global Codeine Tablet Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Codeine Tablet Sales Value Market Share by Country (2021-2026) Table 62. Global Codeine Tablet Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Codeine Tablet Sales Value Market Share by Country (2027-2032) Table 64. TEVA Company Information Table 65. TEVA Business Overview Table 66. TEVA Codeine Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. TEVA Codeine Tablet Product Portfolio Table 68. TEVA Recent Development Table 69. Johnson & Johnson Company Information Table 70. Johnson & Johnson Business Overview Table 71. Johnson & Johnson Codeine Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Johnson & Johnson Codeine Tablet Product Portfolio Table 73. Johnson & Johnson Recent Development Table 74. Novartis Company Information Table 75. Novartis Business Overview Table 76. Novartis Codeine Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Novartis Codeine Tablet Product Portfolio Table 78. Novartis Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Codeine Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Mylan Codeine Tablet Product Portfolio Table 83. Mylan Recent Development Table 84. Taiji Company Information Table 85. Taiji Business Overview Table 86. Taiji Codeine Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Taiji Codeine Tablet Product Portfolio Table 88. Taiji Recent Development Table 89. Sanofi Aventis Company Information Table 90. Sanofi Aventis Business Overview Table 91. Sanofi Aventis Codeine Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Sanofi Aventis Codeine Tablet Product Portfolio Table 93. Sanofi Aventis Recent Development Table 94. Pharmaceutical Associates Company Information Table 95. Pharmaceutical Associates Business Overview Table 96. Pharmaceutical Associates Codeine Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Pharmaceutical Associates Codeine Tablet Product Portfolio Table 98. Pharmaceutical Associates Recent Development Table 99. Medreich Company Information Table 100. Medreich Business Overview Table 101. Medreich Codeine Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Medreich Codeine Tablet Product Portfolio Table 103. Medreich Recent Development Table 104. Mallinckrodt Company Information Table 105. Mallinckrodt Business Overview Table 106. Mallinckrodt Codeine Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Mallinckrodt Codeine Tablet Product Portfolio Table 108. Mallinckrodt Recent Development Table 109. Lannett Company Company Information Table 110. Lannett Company Business Overview Table 111. Lannett Company Codeine Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Lannett Company Codeine Tablet Product Portfolio Table 113. Lannett Company Recent Development Table 114. Laboratoire Riva Company Information Table 115. Laboratoire Riva Business Overview Table 116. Laboratoire Riva Codeine Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Laboratoire Riva Codeine Tablet Product Portfolio Table 118. Laboratoire Riva Recent Development Table 119. Hikma Company Information Table 120. Hikma Business Overview Table 121. Hikma Codeine Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Hikma Codeine Tablet Product Portfolio Table 123. Hikma Recent Development Table 124. Cipla Company Information Table 125. Cipla Business Overview Table 126. Cipla Codeine Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Cipla Codeine Tablet Product Portfolio Table 128. Cipla Recent Development Table 129. Aristo Pharma GmbH Company Information Table 130. Aristo Pharma GmbH Business Overview Table 131. Aristo Pharma GmbH Codeine Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Aristo Pharma GmbH Codeine Tablet Product Portfolio Table 133. Aristo Pharma GmbH Recent Development Table 134. Apotex Company Information Table 135. Apotex Business Overview Table 136. Apotex Codeine Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Apotex Codeine Tablet Product Portfolio Table 138. Apotex Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Codeine Tablet Distributors List Table 142. Codeine Tablet Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Codeine Tablet Product Image Figure 2. Global Codeine Tablet Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Codeine Tablet Sales Value (2021-2032) & (US$ Million) Figure 4. Global Codeine Tablet Sales (2021-2032) & (K Units) Figure 5. Global Codeine Tablet Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Codeine Tablet Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Single-ingredient Codeine Image Figure 10. Multi-ingredient Medications Image Figure 11. Global Codeine Tablet Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Codeine Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Codeine Tablet Sales Volume Share by Type (2021-2032) Figure 14. Global Codeine Tablet Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Codeine Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Codeine Tablet Sales Value Share by Type (2021-2032) Figure 17. Narcotic Analgesic Image Figure 18. Antitussive Image Figure 19. Others Image Figure 20. Global Codeine Tablet Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Codeine Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Codeine Tablet Sales Volume Share by Application (2021-2032) Figure 23. Global Codeine Tablet Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Codeine Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Codeine Tablet Sales Value Share by Application (2021-2032) Figure 26. Global Codeine Tablet Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Codeine Tablet Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Codeine Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Codeine Tablet Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Codeine Tablet Sales Value (2021-2032) & (US$ Million) Figure 31. North America Codeine Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Codeine Tablet Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Codeine Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Codeine Tablet Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Codeine Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Codeine Tablet Sales Value (2021-2032) & (US$ Million) Figure 37. South America Codeine Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Codeine Tablet Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Codeine Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Codeine Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Codeine Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Codeine Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Codeine Tablet Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Codeine Tablet Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Single-ingredient Codeine
  • Multi-ingredient Medications
Applications
  • Narcotic Analgesic
  • Antitussive
  • Others
Companies covered
  • TEVA
  • Johnson & Johnson
  • Novartis
  • Mylan
  • Taiji
  • Sanofi Aventis
  • Pharmaceutical Associates
  • Medreich
  • Mallinckrodt
  • Lannett Company
  • Laboratoire Riva
  • Hikma
  • Cipla
  • Aristo Pharma GmbH
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Codeine Tablet Sales Value (2021-2032)
  4. 1.2.2 Global Codeine Tablet Sales Volume (2021-2032)
  5. 1.2.3 Global Codeine Tablet Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Codeine Tablet Market Dynamics
  1. 2.1 Codeine Tablet Industry Trends
  2. 2.2 Codeine Tablet Industry Drivers
  3. 2.3 Codeine Tablet Industry Opportunities and Challenges
  4. 2.4 Codeine Tablet Industry Restraints
3 Codeine Tablet Market by Company
  1. 3.1 Global Codeine Tablet Company Revenue Ranking in 2025
  2. 3.2 Global Codeine Tablet Revenue by Company (2021-2026)
  3. 3.3 Global Codeine Tablet Sales Volume by Company (2021-2026)
  4. 3.4 Global Codeine Tablet Average Price by Company (2021-2026)
  5. 3.5 Global Codeine Tablet Company Ranking (2024-2026)
  6. 3.6 Global Codeine Tablet Company Manufacturing Base and Headquarters
  7. 3.7 Global Codeine Tablet Company Product Type and Application
  8. 3.8 Global Codeine Tablet Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Codeine Tablet Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Codeine Tablet Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Codeine Tablet Market by Type
  1. 4.1 Codeine Tablet Type Introduction
  2. 4.1.1 Single-ingredient Codeine
  3. 4.1.2 Multi-ingredient Medications
  4. 4.2 Global Codeine Tablet Sales Volume by Type
  5. 4.2.1 Global Codeine Tablet Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Codeine Tablet Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Codeine Tablet Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Codeine Tablet Sales Value by Type
  9. 4.3.1 Global Codeine Tablet Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Codeine Tablet Sales Value by Type (2021-2032)
  11. 4.3.3 Global Codeine Tablet Sales Value Share by Type (2021-2032)
5 Codeine Tablet Market by Application
  1. 5.1 Codeine Tablet Application Introduction
  2. 5.1.1 Narcotic Analgesic
  3. 5.1.2 Antitussive
  4. 5.1.3 Others
  5. 5.2 Global Codeine Tablet Sales Volume by Application
  6. 5.2.1 Global Codeine Tablet Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Codeine Tablet Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Codeine Tablet Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Codeine Tablet Sales Value by Application
  10. 5.3.1 Global Codeine Tablet Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Codeine Tablet Sales Value by Application (2021-2032)
  12. 5.3.3 Global Codeine Tablet Sales Value Share by Application (2021-2032)
6 Codeine Tablet Regional Sales and Value Analysis
  1. 6.1 Global Codeine Tablet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Codeine Tablet Sales by Region (2021-2032)
  3. 6.2.1 Global Codeine Tablet Sales by Region: 2021-2026
  4. 6.2.2 Global Codeine Tablet Sales by Region (2027-2032)
  5. 6.3 Global Codeine Tablet Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Codeine Tablet Sales Value by Region (2021-2032)
  7. 6.4.1 Global Codeine Tablet Sales Value by Region: 2021-2026
  8. 6.4.2 Global Codeine Tablet Sales Value by Region (2027-2032)
  9. 6.5 Global Codeine Tablet Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Codeine Tablet Sales Value (2021-2032)
  12. 6.6.2 North America Codeine Tablet Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Codeine Tablet Sales Value (2021-2032)
  15. 6.7.2 Europe Codeine Tablet Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Codeine Tablet Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Codeine Tablet Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Codeine Tablet Sales Value (2021-2032)
  21. 6.9.2 South America Codeine Tablet Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Codeine Tablet Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Codeine Tablet Sales Value Share by Country, 2025 VS 2032
7 Codeine Tablet Country-level Sales and Value Analysis
  1. 7.1 Global Codeine Tablet Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Codeine Tablet Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Codeine Tablet Sales by Country (2021-2032)
  4. 7.3.1 Global Codeine Tablet Sales by Country (2021-2026)
  5. 7.3.2 Global Codeine Tablet Sales by Country (2027-2032)
  6. 7.4 Global Codeine Tablet Sales Value by Country (2021-2032)
  7. 7.4.1 Global Codeine Tablet Sales Value by Country (2021-2026)
  8. 7.4.2 Global Codeine Tablet Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Codeine Tablet Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Codeine Tablet Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Codeine Tablet Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Codeine Tablet Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Codeine Tablet Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Codeine Tablet Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Codeine Tablet Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Codeine Tablet Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Codeine Tablet Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Codeine Tablet Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Codeine Tablet Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Codeine Tablet Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Codeine Tablet Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Codeine Tablet Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Codeine Tablet Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Codeine Tablet Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Codeine Tablet Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Codeine Tablet Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Codeine Tablet Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Codeine Tablet Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Codeine Tablet Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Codeine Tablet Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Codeine Tablet Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Codeine Tablet Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Codeine Tablet Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Codeine Tablet Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Codeine Tablet Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Codeine Tablet Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Codeine Tablet Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Codeine Tablet Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Codeine Tablet Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 TEVA
  2. 8.1.1 TEVA Company Information
  3. 8.1.2 TEVA Business Overview
  4. 8.1.3 TEVA Codeine Tablet Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 TEVA Codeine Tablet Product Portfolio
  6. 8.1.5 TEVA Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Codeine Tablet Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Codeine Tablet Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Codeine Tablet Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Codeine Tablet Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Codeine Tablet Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Codeine Tablet Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Taiji
  26. 8.5.1 Taiji Company Information
  27. 8.5.2 Taiji Business Overview
  28. 8.5.3 Taiji Codeine Tablet Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Taiji Codeine Tablet Product Portfolio
  30. 8.5.5 Taiji Recent Developments
  31. 8.6 Sanofi Aventis
  32. 8.6.1 Sanofi Aventis Company Information
  33. 8.6.2 Sanofi Aventis Business Overview
  34. 8.6.3 Sanofi Aventis Codeine Tablet Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi Aventis Codeine Tablet Product Portfolio
  36. 8.6.5 Sanofi Aventis Recent Developments
  37. 8.7 Pharmaceutical Associates
  38. 8.7.1 Pharmaceutical Associates Company Information
  39. 8.7.2 Pharmaceutical Associates Business Overview
  40. 8.7.3 Pharmaceutical Associates Codeine Tablet Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Pharmaceutical Associates Codeine Tablet Product Portfolio
  42. 8.7.5 Pharmaceutical Associates Recent Developments
  43. 8.8 Medreich
  44. 8.8.1 Medreich Company Information
  45. 8.8.2 Medreich Business Overview
  46. 8.8.3 Medreich Codeine Tablet Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Medreich Codeine Tablet Product Portfolio
  48. 8.8.5 Medreich Recent Developments
  49. 8.9 Mallinckrodt
  50. 8.9.1 Mallinckrodt Company Information
  51. 8.9.2 Mallinckrodt Business Overview
  52. 8.9.3 Mallinckrodt Codeine Tablet Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Mallinckrodt Codeine Tablet Product Portfolio
  54. 8.9.5 Mallinckrodt Recent Developments
  55. 8.10 Lannett Company
  56. 8.10.1 Lannett Company Company Information
  57. 8.10.2 Lannett Company Business Overview
  58. 8.10.3 Lannett Company Codeine Tablet Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Lannett Company Codeine Tablet Product Portfolio
  60. 8.10.5 Lannett Company Recent Developments
  61. 8.11 Laboratoire Riva
  62. 8.11.1 Laboratoire Riva Company Information
  63. 8.11.2 Laboratoire Riva Business Overview
  64. 8.11.3 Laboratoire Riva Codeine Tablet Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Laboratoire Riva Codeine Tablet Product Portfolio
  66. 8.11.5 Laboratoire Riva Recent Developments
  67. 8.12 Hikma
  68. 8.12.1 Hikma Company Information
  69. 8.12.2 Hikma Business Overview
  70. 8.12.3 Hikma Codeine Tablet Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Hikma Codeine Tablet Product Portfolio
  72. 8.12.5 Hikma Recent Developments
  73. 8.13 Cipla
  74. 8.13.1 Cipla Company Information
  75. 8.13.2 Cipla Business Overview
  76. 8.13.3 Cipla Codeine Tablet Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Cipla Codeine Tablet Product Portfolio
  78. 8.13.5 Cipla Recent Developments
  79. 8.14 Aristo Pharma GmbH
  80. 8.14.1 Aristo Pharma GmbH Company Information
  81. 8.14.2 Aristo Pharma GmbH Business Overview
  82. 8.14.3 Aristo Pharma GmbH Codeine Tablet Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Aristo Pharma GmbH Codeine Tablet Product Portfolio
  84. 8.14.5 Aristo Pharma GmbH Recent Developments
  85. 8.15 Apotex
  86. 8.15.1 Apotex Company Information
  87. 8.15.2 Apotex Business Overview
  88. 8.15.3 Apotex Codeine Tablet Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Apotex Codeine Tablet Product Portfolio
  90. 8.15.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Codeine Tablet Value Chain Analysis
  2. 9.1.1 Codeine Tablet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Codeine Tablet Sales Mode & Process
  6. 9.2 Codeine Tablet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Codeine Tablet Distributors
  9. 9.2.3 Codeine Tablet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst